Additionally, ECM-rich myCAF signatures have been correlated with increased T cell dysfunction, as indicated by the elevated expression of checkpoint molecules, such as PD-1 and CTLA-4, on tumor-infiltrating lymphocytes [72]. The gene discussed is PDCD1; the disease is neoplasm.